Indian Immunologicals Ltd (IIL), a subsidiary of National Dairy Development Board (NDDB) and a leading biopharmaceutical company in India, launched the first indigenously developed Hepatitis A vaccine “Havisure” on Friday at Hyatt Place here. The chief guests of the event were Nagaraj Karpan, MLA and Ajay Mishra, Chairman Indian Red Cross Society.
The vaccine represented a significant step forward in India’s fight against Hepatitis A and is poised to make a substantial contribution to public health.
Havisure is the result of extensive research and development efforts by IIL’s team of scientists and researchers. This vaccine is poised to play a crucial role in preventing Hepatitis A, a highly contagious liver infection that poses a significant public health challenge.
